EUCTR2007-002431-80-IT进行中（未招募）不适用
Renal Effects of Levosimendan in Patients Admitted with Acute Decompensated Heart Failure - ND
AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA0 个研究点开始时间: 2009年3月23日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. An ejection fraction (EF) lower than 40% by transthoracic echocardiogram by Simpson`s rule. 2. Wedge pressure (PCWP) higher than 20 mmHg. 3. Mild-moderate renal impairment. 4. A Standard therapy for HF that should include angiotensin converting enzyme inhibitors, angiotensin receptor blockers, aldosterone blocking agents (spironolactone) and beta-blockers, unless controindicated
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Patients receiving other oral or i.v. inodilators. 2. Oral or i.v. diuretics. 3. Patients with systolic blood pressure <110 mmHg. 4. Mechanical ventilation. 5. Sustained ventricular tachycardia or ventricular fibrillation. 6. Severe aortic or mitral regurgitation. 7. Documented renal artery stenosis, requiring dyalisis. 8. Left ventricular failure primarily from uncorrected obstructive valvular disease, hypertrophic obstructive cardiomyopathy, restrictive/obstructive cardiomyopathy. 9. Uncorrected thyroid disease, 10. Known amyloid cardiomiopathy 11. Known malfunctioning artificial heart valve.
研究者
相似试验
Unknown
4 期
Renal Effects of Levosimendan in Patients Admitted With Acute Decompensated Heart FailureHeart FailureRenal InsufficiencyNCT00527059University of Roma La Sapienza21
进行中（未招募）
不适用
Comparison between levosimendan and placebo in acute renal failure after cardiac surgeryAcute kidney injury postoperatively in connection with heart surgeryEUCTR2014-003589-25-SESahlgrenska Universitetssjukhuset/Sahlgrenska
招募中
1 期
Effects of Levosimendan in patients being weaned from venoarterial extracorporal membrane oxygenation. A randomized controlled investigator driven phase II trialCardiogenic ShockCTIS2023-508024-36-00Allgemeines Krankenhaus Der Stadt Wien Universitatskliniken46
已完成
4 期
The Effects of Levosimendan During Mitral Valve SurgeryMitral Valve Stenosis With Incompetence or RegurgitationNCT01969071Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital140
已完成
不适用
Comparison of Levosimendan and Dobutamine in cardiac surgeryCirculatory SystemHeart failureISRCTN54237076ational Medical Center 'La Raza'24